NCT05355701 2026-02-03A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.PfizerPhase 1 Recruiting267 enrolled
NCT00101270 2013-06-05Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasNational Cancer Institute (NCI)Phase 1 Completed24 enrolled